CONTACT
API Products
API Sourcing
Strategic Sourcing
505(b)(2) Pathway
Regulatory Support
Logistics
Manufacturer Management Program
CDMO Services
Formulation Development
Solid Dose Delivery Systems
Liquids / Suspensions
Semi-Solids
Suppositories
Commercial Scale-Up Facilities & Equipment
Regulatory Management
Analytical Services
Analytical Testing
Stability Services
Resources
About LGM
Quality Commitment
Leadership
Company History
Clients
News
Events
Careers
Blog
Contact
Listing Page
Tag: COVID-19
The Impact of COVID-19 on Pharma Markets
May 30, 2021
The pandemic has left a substantial impact on our world that will be felt for years to come. It has led...
Read More >
Reshoring Early-Stage Pharma
February 28, 2021
The Emergence of a Post COVID-19 Risk Mitigation Strategy Over the last few decades, pharma companies...
Read More >
Can the U.S. Stop Buying Drugs from China?
October 04, 2020
The SARS-CoV-2 pandemic has drawn significant attention to just how much US pharmaceutical manufacturers...
Read More >
A Look at Reshoring Drug Manufacturing: A Q&A With LGM Pharma’s Hamilton Lenox
June 08, 2020
When SARS-CoV-2 arrived on American shores this Spring, concerns about overextended drug supply chains...
Read More >
Search
Categories
Categories
505b2
Analytical Services
API Sourcing
blog
Bulk Active Ingredient
CDMO Services
Dosage Forms
Drug Manufacturing
Drug Research & Development API
Formulation Development
LGM Pharma
Liquids/Suspensions
Logistics
Manufacturer Qualification
Press Release
Quality By Design
Regulatory
Regulatory Management
Regulatory Support
Semi-Solids
Solid Dose
Strategic Sourcing
Supply Chain
How can we help?
Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
Privacy policy
